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Abstract 25 
There is now general agreement that neurokinin B (NKB) acts via NK3R to stimulate secretion of 26 
gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) in a number of species, including 27 
rats, mice, sheep, and humans. However the roles of two other tachykinins, substance P (SP) and 28 
neurokinin A (NKA), which act primarily via NK1R and NK2R respectively, are less clear. In rodents, 29 
these signaling pathways can stimulate LH release and substitute for NKB signaling; in humans, SP is 30 
colocalized with kisspeptin and NKB in the mediobasal hypothalamus.  In this study, we examined the 31 
possible role of these tachykinins in control of the reproductive axis in sheep. Immunocytochemistry was 32 
used to describe the expression of SP and NK1R in the ovine diencephalon and determine if these 33 
proteins are colocalized in kisspeptin or GnRH neurons.  SP-containing neurons were largely confined to 34 
the arcuate nucleus (ARC), but NK1R-immunoreactivity was more widespread, with relatively high 35 
expression in the lateral preoptic area, the ventromedial nucleus, and the ARC.  However, there was very 36 
low coexpression of SP or NK1R in kisspeptin cells and none in GnRH neurons. We next determined the 37 
minimal effective dose of these three tachykinins that would stimulate LH secretion when administered 38 
into the third cerebral ventricle of ovary-intact anestrous sheep. A much lower dose of NKB (0.2 nmoles) 39 
than of NKA (2 nmoles) or SP (10 nmoles) consistently stimulated LH secretion.  Moreover, the relative 40 
potency of these three neuropeptides parallels the relative selectively of NK3R.  Based on these 41 
anatomical and pharmacological data, we conclude that NKB-NK3R signaling is the primary pathway for 42 
the control of GnRH secretion by tachykinins in ewes. 43 
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Introduction 44 
Recent studies (1-3) on the reproductive effects of mutations in the TAC3 gene that encodes neurokinin B 45 
(NKB) or in the gene (TACR3) that encodes its receptor (NK3R) have focused the attention of 46 
reproductive neuroendocrinologists on the possible roles of tachykinins in control of gonadotropin-47 
releasing hormone (GnRH), luteinizing hormone (LH), and follicle stimulating hormone (FSH) secretion.  48 
In addition to NKB, two other tachykinins have been implicated in the control of reproduction: substance 49 
P (SP) and neurokinin A (NKA). These peptides are both encoded by the same gene (TAC1) and act via 50 
NK1R and NK2R, respectively (4,5). At this time there are no reports that mutations in TAC1 or the genes 51 
for NK1R or NK2R produce reproductive deficits in humans, but other approaches have implicated these 52 
two tachykinins in the control of GnRH secretion (4). 53 
  A stimulatory role for NKB in control of GnRH in humans was first proposed in 1991 based on 54 
the increase in NKB expression in post-menopausal women within the infundibular nucleus (6), which is 55 
analogous to the arcuate nucleus (ARC) in other species. These cells also contain kisspeptin and 56 
dynorphin and thus are now known as KNDy neurons (7,8). More recently, work across a number of 57 
species, spurred on by the human genetic studies, has produced considerable evidence in support of this 58 
hypothesis.  In most studies NKB, or more often senktide (an NK3R agonist), stimulated LH secretion via 59 
GnRH in gonadally-intact animals or when LH secretion was suppressed with exogenous steroids (9-13).  60 
Conversely, antagonists to NK3R inhibited LH secretion in ovariectomized (OVX) sheep (14-16), 61 
castrated monkeys (16), and normal men and women (17).  Interestingly most, but not all (18), studies 62 
indicate that these stimulatory effects are mediated by kisspeptin released from KNDy neurons. Thus, 63 
KNDy neurons contain NK3R (19-21) and NKB, or senktide, increased their activity, based on Fos 64 
expression, in vivo (22,23) or electrical activity in hypothalamic slices (13,24,25). Moreover, these 65 
agonists did not stimulate LH secretion in the absence of Kiss1r in mice (26), in the presence of a Kiss1r 66 
antagonist in rats (27), or when Kiss1r was down-regulated in primates (28).  In contrast to these 67 
stimulatory effects of senktide when endogenous GnRH secretion is low, this NK3R agonist inhibits LH 68 
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secretion in OVX rats (29,30) and mice (21), probably by stimulating dynorphin release from KNDy 69 
neurons (31). 70 
 There are fewer studies on the roles of SP and NKA, but recent work in rodents indicates that 71 
these tachykinins can have effects similar to NKB on LH and FSH secretion.  Thus NKA and SP 72 
increased the firing rate of murine KNDy neurons in vitro (25) and specific NK1R or NK2R agonists 73 
increased LH and FSH secretion in rats (32) and mice (12), with the latter effects being dependent on 74 
Kiss1r signaling (12).  Similarly knockout of Tac1 delayed puberty and decreased ovulation rate and the 75 
number of pups/litter in mice (33).  Finally, there may well be some redundancy among the three 76 
tachykinin signaling pathways in rodents because blockade of all three receptors is required to inhibit LH 77 
secretion in OVX rats (34).   Similarly, stimulatory effects of NKB on the electrical activity of murine 78 
KNDy neurons in vitro is not blocked by each selective NKR antagonist alone, but is blocked by a 79 
cocktail of all three receptor antagonists (25). 80 
 The limited work on SP and NKA in other species has largely focused on the former. In humans, 81 
infusion of SP stimulated LH, but not FSH, secretion (35) and SP expression in the infundibular nucleus 82 
is higher in post-menopausal women than in pre-menopausal women (6) and higher than expression in 83 
both young and aged men (36). Immunocytochemical (ICC) studies using tissue from post-menopausal 84 
women indicated that 25% of NKB-containing and 31% of kisspeptin-containing cell bodies also 85 
expressed SP (36) and similar colocalization was observed in close contacts with GnRH axonal fibers in 86 
the median eminence (37). On the other hand, in male rhesus monkeys, SP was not found in kisspeptin-87 
containing neurons and iv injection of SP failed to stimulate LH secretion (38).  Moreover, an NK1R 88 
antagonist increased both LH and FSH concentrations during the descending phase of an estrogen-89 
induced surge in cynomologus monkeys, suggesting a possible inhibitory effect of SP (39). 90 
Studies in sheep have provided important information on the expression and actions of NKB 91 
(8,9,14-16,19,40), but there is no information in this species on the role of other tachykinins in control of 92 
GnRH secretion.  This work addressed this gap in our knowledge by: 1) describing the expression of SP 93 
and NK1R in the ovine preoptic area (POA) and hypothalamus, 2) determining if either was colocalized 94 
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with kisspeptin- or GnRH-containing neurons and the effect of estradiol (E2) on their expression, and 3) 95 
comparing the minimal dose of NKB, SP, and NKA required to stimulate LH secretion in ovary-intact 96 
anestrous ewes. We chose to monitor LH concentrations because they provide a reliable index of episodic 97 
GnRH secretion. In contrast, patterns of FSH do not reflect endogenous GnRH pulses (41) and FSH 98 
elevations are not seen in response to exogenous GnRH injections that produce LH pulses (41,42).  99 
 100 
Materials & Methods 101 
Animals 102 
Adult (4-8 years of age) multiparous blackface ewes of predominantly Suffolk breeding were maintained 103 
in an open barn and moved indoors 3–7 days prior to surgeries. Ewes were fed a pelleted alfalfa diet to 104 
maintain weight (65-85 kg) and provided free access to water and supplemental minerals. Lighting was 105 
adjusted bimonthly to mimic the duration of natural day light. All experiments used anestrous ewes and 106 
were performed between the middle of April and the end of July.  107 
Surgical and blood collection procedures 108 
All surgeries were performed under aseptic conditions using 2-4 % isofluorane in oxygen for anesthesia. 109 
For OVX, ovaries were exposed via mid-ventral laporatomy, the blood supply ligated, and the ovaries 110 
removed.  Any blood clots adhering to the uterus or oviducts were then removed with sterile saline, these 111 
organs returned to the abdomen, and the peritoneum and skin were sutured closed.  For 112 
intracerebroventricular (icv) administration of tachykinins, an 18-gauge stainless steel cannula was 113 
stereotaxically placed into the third ventricle, cemented in place with dental acrylic, protected with a 114 
plastic cap, and the hub plugged to prevent CSF backflow (43).  All ewes were treated with 115 
dexamethasone and penicillin from 1 day before to 5 days after surgery, and with analgesic (125 mg; 116 
Banamine, Phoenix Pharmaceutical, St. Joseph, MO) at the time of anesthesia induction and for 5 days 117 
after surgery. Animals were allowed to recover from surgical procedures for at least 7 days before any 118 
experimental treatments.  Jugular blood samples (3-4 mL) were taken by venipuncture, placed in 119 
heparinized tubes, and plasma collected and stored at -20 C until assayed for LH.  All procedures were 120 
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approved by the West Virginia University Animal Care and Use Committee and conducted in accordance 121 
with NIH guidelines on the care and use of animals in research. 122 
Tissue collection 123 
Paraformaldhyde-fixed tissue was collected for immunocytochemistry and histological determination of 124 
treatment sites. Ewes were injected with two doses of 20,000 units of heparin (10 mins apart) and then 125 
euthanized with an overdose (8–12 mL, iv) of sodium pentobarbital (Euthasol; Patterson Veterinary, 126 
Devens, MA). The head was removed when the animal had stopped breathing and perfused via the 127 
internal carotids with 6 L of 4 % paraformaldehyde in 0.1 M phosphate buffer containing 0.1 % NaNO3. 128 
Tissue blocks containing hypothalamus and preoptic area (POA) were removed and stored in fixative at 4 129 
°C overnight and then in 20% sucrose. After sucrose infiltration, 45-μm-thick frozen coronal sections 130 
were cut using a freezing microtome. For ICC, 6 parallel series of sections (270 μm apart) were stored at -131 
20 °C in cryoprotectant. 132 
Experiments 1 and 2.  Distribution, colocalization with kisspeptin or GnRH and effect of E2 on SP and 133 
NK1R expression. 134 
All immunohistochemical studies were conducted on tissue collected from a cohort of anestrous ewes that 135 
did not undergo intracranial surgeries.  Anestrous animals were OVX, as described above, and a 3 cm 136 
long E2-containing Silastic implant was inserted subcutaneously (s.c.) (OVX+ E2; n=5) or sham inserted 137 
(OVX; n=5) at the end of the surgical procedure.  Animals were perfused, as described above, and tissue 138 
was collected 10 days later. 139 
Experiment 3.  LH dose-response to NKB in ovary-intact anestrous ewes 140 
Chronic cannulae were placed in the third ventricle of ovary-intact anestrous ewes (n=4) in the middle of 141 
April.  This experiment was done in ovary-intact ewes to avoid multiple survival surgeries. A stock 142 
solution of NKB (Tocris Bioscience, Ellisville MO) was prepared the day before the first treatments by 143 
dissolving 0.6 mg NKB in 0.375 mL of 0.1 N NaOH (1 nmole/µL) (44). Aliquots of this stock solution 144 
were stored at -20 C, and then thawed and diluted with sterile artificial CSF (aCSF) (45) on the day of 145 
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treatments to produce concentrations ranging from 0.05 to 0.5 nmoles/100 µL. Because the stock was 146 
diluted 1:200 to prepare the highest dose of NKB, we used 0.1 N NaOH diluted 1:200 with aCSF as 147 
vehicle for the 0 nmole treatment.  This study was originally designed to determine a dose of NKB that 148 
would reliably induce a physiological LH pulse for analysis of receptor turnover (46), so LH was only 149 
monitored for 2 hr after injection.  Starting 9-10 days after surgery, blood samples were collected every 150 
12 min from 24 min before to 2 hrs after icv injection (100 µL) of 0 (100 µL of vehicle), 0.05 nmoles 151 
NKB, 0.1 nmoles NKB, 0.2 nmoles NKB, or 0.5 nmoles NKB.  This protocol was then repeated four 152 
more times, with 3-5 days between treatments so that all animals received all five treatments in a random 153 
order.  Tissue was collected after the last treatment and location of cannulae in the third ventricle 154 
confirmed. In a follow-up experiment the response to 0.2 nmoles of NKB was assessed in a separate set of 155 
five ovary-intact anestrous ewes using this protocol. 156 
Experiment 4.  What doses of NKA and SP are needed to stimulate LH secretion in ovary-intact anestrous 157 
ewes? 158 
Chronic third ventricle cannulae were implanted in 5 ovary-intact ewes in early June. This experiment 159 
was designed to test two doses of NKA and SP.  Based on the results of Exp. 3, and the relative potency 160 
of NKB, SP, and NKA in stimulating electrical activity of KNDy neurons in mice (25), we first compared 161 
the effects of 2 nmoles of NKA and SP with vehicle controls. We then planned to either increase or 162 
decrease the dose of these tachykinins based on the effects at this dose, which resulted in administration 163 
of 0.5 nmoles NKA and 10 nmoles of SP to these ewes in the second part of this experiment.  Stock 164 
solutions of 0.5 nmoles tachykinin/µL of aCSF were prepared before the first treatment, aliquots frozen, 165 
and diluted with aCSF to the appropriate concentration on the morning of all treatments.  Starting two 166 
weeks after neurosurgery, ewes received icv injections of either aCSF, 2 nmoles NKA, or 2 nmoles SP in 167 
random order with 3-4 days between treatments.  LH concentrations were measured in plasma samples 168 
collected from 36 min before to 4 hr after injections.  One week after the last set of injections, samples 169 
were again collected for 36 min before to 4 hr after injection of either 0.5 nmoles NKA or 10 nmoles SP, 170 
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and this treatment repeated with a cross-over design so that each ewe received both treatments. At the end 171 
of the experiment, tissue was collected to confirm that cannulae were in the third ventricle. 172 
Immunohistochemistry 173 
Free floating, double-label, immunofluorescence histochemistry was performed in order to determine the 174 
distribution of SP and NK1R, and investigate their potential colocalization with kisspeptin and/or GnRH 175 
in the sheep POA and hypothalamus.  Furthermore, we processed tissue sections from OVX and OVX+ 176 
E2 ewes to determine whether E2 regulates protein expression of SP or NK1R. Hence, a series of every 177 
sixth section, extending from the level of the optic chiasma to the mammillary bodies, was processed for 178 
each of the following four combinations: a) SP and kisspeptin, b) NK1R and kisspeptin, c) SP and GnRH, 179 
or d) NK1R and GnRH using a modified protocol previously described and routinely used in our 180 
laboratory (8). Briefly, all steps were performed at room temperature and with gentle agitation, and tissue 181 
sections were washed with 0.1M phosphate buffered (pH 7.35) saline (PBS) between each step. 182 
Antibodies were diluted in PBS+, a solution consisting of 0.1M PBS, 0.4% Triton X-100 (Sigma-Aldrich, 183 
St. Louis MO ) and 4% normal goat serum (Jackson ImmunoResearch Labortories, West Grove, PA). 184 
Before the application of the first primary antibody, sections were treated with 1% hydrogen peroxide 185 
(H2O2) for 10 min followed by PBS+ for 1 hr to prevent nonspecific background labeling. Tissue sections 186 
were then incubated sequentially with: 1) guinea pig anti-SP (1:4,000, Abcam, Cambridge, MA; Table 1) 187 
or rabbit anti-NK1R (1:10,000, Millipore, Billerica, MA; Table 1) for 17 hr, 2) biotinylated goat anti-188 
guinea pig IgG (1:500, Vector Laboratories, Burlingame, CA) or anti-rabbit IgG (1:500, Vector 189 
Laboratories), respectively, for 1 hr, 3) avidin and biotinylated horseradish peroxidase complex (Avidin-190 
Biotin Complex, 1:500, Vector Laboratories) for 1 hr, 4) biotinylated tyramine (1:250, PerkinElmer, 191 
Waltham, MS), containing  0.003% H2O2 for 10 min, and 5) Alexa Fluor 555 conjugated streptavidin 192 
(1:100, Invitrogen, Carlsbad, CA) for 30 min. Tissue was protected from light from this step forward. 193 
Next, sections were incubated with rabbit anti-kisspeptin (1:1,000, Millipore; Table 1) or rabbit anti-194 
GnRH (1:400, Immunostar, Hudson, WI; Table 1) for 17 hr.  After overnight incubation, sections were 195 
washed and incubated with goat anti-rabbit DyLight green (1:100, Vector Laboratories) for 1 hr. Tissue 196 
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sections were mounted onto slides, air dried, coverslipped with Gelvatol mounting medium, and stored at 197 
4°C until analysis. Negative controls were routinely performed by omission of primary antibody, which 198 
eliminated all labeling corresponding to that antigen. In addition, specificity of the SP antibody was tested 199 
using peptide blocking controls (47). In short, preabsorption (overnight at 40C) of the guinea pig-anti-SP 200 
antibody with 15 g/ml of the corresponding SP peptide (Abcam, catalog item ab38217) abolished all 201 
staining in the ovine POA and hypothalamus. No blocking peptide was available for the NK1R antibody, 202 
but the complete mismatch with the distribution of NK3R (see Results) and reported absence of NK2R in 203 
the hypothalamus (48) support the specificity of this antibody. 204 
Image capture and analysis. 205 
The distribution of SP and NK1R was examined in sections through the POA and hypothalamus of each 206 
ewe. Colocalization of SP or NK1R with kisspeptin or GnRH as well as the comparison of total cell 207 
number between OVX and OVX+ E2 ewes, was evaluated in sections containing rostral, middle, or caudal 208 
levels of the ARC (four sections each), or POA (six to eight sections each) at 20X magnification. We used 209 
a digital camera (Microfire A/R, Optronics, Goleta, CA) attached to a microscope (DM500B, Leica 210 
Microsystems, Wetzlar, Germany), with the appropriate excitation for DyLight 488 (green fluorescent 211 
protein) and Alexa 555 (red fluorescent protein) and Neurolucida software (MicroBrightfield Bioscience, 212 
Williston, VT) to superimpose the two images and determine colocalization.  For each section, the total 213 
number of single and double labeled (Kiss+SP, Kiss+NK1R, GnRH+SP, GnRH+NK1R) cells were 214 
counted by flipping through the green and red channels. Counts were averaged per ewe, per brain area. 215 
Percentages of the total number of kisspeptin- or GnRH-ir cells containing SP or NK1R as well as the 216 
percentages of SP- or NK1R-ir cells containing kisspeptin or GnRH were calculated for each section, and 217 
averaged per ewe, per brain area.   218 
In addition to cell counts, the effects of E2 on SP fiber density in the ARC was examined because SP cell 219 
bodies where observed infrequently.  A midlevel section of the ARC was selected for imaging and 220 
quantification of the density of SP-containing fibers. Fibers were visualized and photographed with a 20X 221 
objective lens (Microfire A/R). Data from these images were then analyzed using Image J software (NIH, 222 
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Bethesda, MD). A standardized threshold was applied to all images and the proportion of immunolabeling 223 
above threshold was quantified for each section. Therefore the data represent the proportional area 224 
occupied by labeled fibers, not the specific number of fibers. Two images per animal were analyzed and 225 
these data averaged to obtain values for that animal. Group data are expressed as the mean ± SEM.  226 
 227 
LH Assay  228 
Ovine LH concentrations in plasma (200 µL) were measured in duplicate with a RIA using reagents 229 
provided by the National Hormone and Peptide Program as previously described (49). The sensitivity of 230 
the assay averaged 0.04 ng/tube (NIH S24) and the intra- and interassay coefficients of variation were 231 
5.9% and 9.8%, respectively. 232 
 233 
Statistical analyses 234 
For Exp. 2, the number of single-labeled kisspeptin, GnRH, or NKR1 perikarya were compared between 235 
OVX and OVX+ E2 groups using a two-way ANOVA (region and hormone treatment as main factors) 236 
and Holm-Sidak posthoc test, whenever appropriate. Densities of SP fibers in the ARC were compared 237 
between OVX and OVX+ E2 groups by t-test.  For analysis of the effects of tachykinins on LH secretion 238 
(Exp. 3 and 4), an increase in LH concentrations following injection of a tachykinin was considered to be 239 
a response if it occurred within 2 samples of the injection and peak LH concentrations were two SD above 240 
the preinjection value, based on assay variability.  For Exp. 3, mean LH concentrations before and  for 0-2 241 
hrs after injection were compared by two-way ANOVA with repeated measures (time and dose of NKB 242 
were the main factors), and the Holm-Sidak test was used for comparisons within treatments. LH pulse 243 
amplitudes and frequencies after injection were determined using established criteria for LH pulses (50).  244 
Amplitudes were analyzed by one-way ANOVA with repeated measures and pulse frequencies by the 245 
non-parametric Kruskal-Wallis one-way ANOVA on Ranks.  For Exp. 4, mean LH concentrations before, 246 
for 0-2 hrs after, and for 2-4 hrs after injection were analyzed for NKA and SP separately using a similar 247 
two-way ANOVA with repeated measures. Initial analysis of LH pulse frequencies and amplitudes in the 248 
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two time bins post-injections indicated no effect of time, so these were analyzed using a simple repeated-249 
measures for the 4 hrs post-injection period.  Specifically, amplitudes were analyzed by one-way 250 
ANOVA with repeated measures and pulse frequencies by the non-parametric Friedman’s repeated 251 
measures ANOVA. P<0.05 was considered statistically significant. 252 
 253 
Results 254 
Experiment 1.  Distribution of SP and NK1R and colocalization with kisspeptin or GnRH in the POA and 255 
hypothalamus. 256 
SP-immunopositive perikarya were observed very infrequently in the mediobasal hypothalamus of OVX 257 
and OVX+ E2 ewes, with more cell bodies identified in the caudal region of the ARC (range 0-10 cell 258 
bodies) compared to middle ( range 0-4 cell bodies) and rostral (range 0-1 cell bodies) regions (Fig. 1 and 259 
2). No SP perikarya were observed in the POA (Fig. 1 and 2B). On the other hand, fibers immunopositive 260 
for SP were observed throughout the entire length of the POA and hypothalamus. In light of the paucity of 261 
SP-containing perikarya, it is not surprising that little colocalization of SP and kisspeptin was observed.  262 
Specifically, colocalization of these two peptides in ARC cell bodies (see Supplemental Fig. 1) was only 263 
observed on three occasions (over 2300 kisspeptin cell bodies analyzed from 10 ewes). However, both 264 
populations of kisspeptin cells (ARC and POA) and their fibers were surrounded by a plethora of SP 265 
immunopositive fibers (Fig. 2A and 2B).  266 
NK1R-containing cells were observed in the diagonal band of Broca, inner outline of the globus pallidus, 267 
anterior hypothalamic area, lateral hypothalamic area, dorsomedial hypothalamus, ventromedial nucleus, 268 
ARC and premammillary nucleus (Fig. 1). Of note, even though NK1R immunopositive cells were 269 
numerous throughout the hypothalamus, they were observed more sparsely in the POA (Fig. 2C-2D and 270 
Fig. 3C-3D). Within the ARC, expression of cell bodies was concentrated mainly in the rostral and caudal 271 
regions (average 34 cell bodies for each) and less in the middle portion of this nucleus (average 18 cell 272 
bodies). Analysis of dual-labeled kisspeptin and NK1R staining revealed infrequent colocalization of these 273 
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two proteins in the ARC (Fig 2C). Specifically, only 6.2 ± 3.3% of kisspeptin neurons were seen to contain 274 
NK1R, and conversely, only 4.6 ± 1.7% of NK1R containing neurons detected in the ARC also expressed 275 
kisspeptin. Similarly to SP, NK1R containing fibers in the ARC where observed in close proximity to 276 
kisspeptin cells (Fig. 2C).  277 
Quantitative analysis of sections throughout the POA and MBH, revealed no colocalization of GnRH in SP 278 
or NK1R-containing neurons (Fig. 3; over 100 GnRH cell bodies analyzed from 10 ewes, for each set of 279 
double-label staining). Similarly, double-labeled fibers were not observed in the ARC or POA. However, 280 
GnRH cells and fibers were intimately surrounded by SP and NK1R immunopositive fibers in the 281 
mediobasal hypothalamus (Fig. 3 and supplemental Fig. 2).  282 
Experiment 2.  Effect of E2 on SP fiber density and NK1R expression in the ARC. 283 
As expected, the presence of E2 downregulated kisspeptin expression in the rostral, middle and caudal 284 
aspects of the ARC (Fig. 4) but had no effect on total GnRH cell numbers (3.9 ± 0.6 and 4.4 ± 1.3 cells in 285 
OVX and OVX+ E2 ewes, respectively).  Quantification of SP fiber density did not reveal differences 286 
between OVX and OVX+ E2 ewes (4.23 ± 1.96 and 4.92 ± 1.26 % of analyzed area above the threshold 287 
for OVX and OVX+ E2 ewes, respectively). Similarly, E2 had no effect on NK1R immunoreactivity in the 288 
rostral, middle or caudal aspects of the ARC (Fig. 4). In the POA, kisspeptin expression was upregulated 289 
by E2 (12.3 ± 4.2 and 38.7 ± 4.2 cells for OVX and OVX+ E2 ewes, respectively; P<0.02) whereas there 290 
was no effect on GnRH expression (18.4 ± 2.7 and 21.4 ± 1.8 cells for OVX and OVX+ E2 ewes, 291 
respectively). No cell bodies immunopositive for SP or NK1R were observed in the vicinity of GnRH 292 
neurons in the POA and therefore this area was not included in the analysis.  293 
Experiment 3.  LH dose-response to NKB in ovary-intact anestrous ewes 294 
None of the ewes treated icv with 0 nmoles NKB had an increase in LH concentrations that met the 295 
criteria for a response and there was only one animal that responded to 0.05 nmoles NKB, whereas doses 296 
of 0.1, 0.2, and 0.5 nmoles NKB produced a response 100% of the time. Based on two-way ANOVA 297 
there was a significant effect of time, dose, and dose by treatment interaction; there were no significant 298 
differences in pre-injection LH concentrations, but mean LH concentrations during the 2 hrs post-299 
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injection of either 0.2 or 0.5 nmoles NKB were significantly greater than those following control 300 
injections (Fig. 5). LH pulse frequency was increased (compared to control injections) when animals were 301 
injected with 0.1, 0.2, or 0.5 nmoles, but not when they received the lowest does of NKB (Table 2). There 302 
were no significant differences among groups in LH pulse amplitude, but only data from the three highest 303 
doses were analyzed because there were too few pulses in ewes receiving 0 and 0.05 nmoles NKB.  In the 304 
follow-up study, 0.2 nmoles NKB again induced a response in all five ewes and increased LH from 1.9 ± 305 
0.3 ng/ml before injection to 3.1 ± 0.4 ng/ml in the 2 hrs post-injection (P=0.015, paired t-test). Pulse 306 
frequencies averaged 1.4 ± 0.2 pulses/2hr and amplitudes were 2.5 ± 0.5 ng/ml after the injection in these 307 
animals. 308 
 309 
 Experiment 4.  What doses of NKA and SP are needed to stimulate LH secretion in ovary-intact 310 
anestrous ewes? 311 
No ewes responded to icv injection of aCSF with an increase in LH concentrations, although 312 
occasional LH pulses occurred either before or 1-3 hrs after injection (Fig 6).  In contrast 80% of the 313 
animals responded to icv injections of 2 nmoles of NKA with a robust and prolonged increment in LH, 314 
but such a response was only observed in 1 of the 5 animals given 2 nmoles SP icv (Fig. 6, left panels).  315 
Consequently, we next tested 0.5 nmoles NKA and 10 nmoles SP (Fig 6, right panels).  With this lower 316 
dose of NKA, one ewe had a robust response immediately following injection of the tachykinin, while 317 
three ewes responded to the higher dose of SP, and the other two appeared to have a somewhat delayed 318 
increase in episodic LH secretion (Fig 6, right panels). 319 
 Statistical analysis of mean LH concentrations indicated there was a dose-response to NKA, with 320 
2 nmoles, but not 0.5 nmoles, producing a significant increase in LH concentrations (Fig. 7A).  However, 321 
this response was fairly brief as LH returned to pre-injection values during the 2-4 hr period.  A similar 322 
dose-response in the effects of NKA on LH pulse frequency after injection was seen, but NKA had no 323 
significant effects on LH pulse amplitude (Fig. 7B). 324 
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SP also produced a significant increase in mean LH concentrations in the first 2 hr period post-325 
injection, but this was only seen with the 10 nmole dose of this tachykinin (Fig. 8A).  Although LH 326 
values were also higher during the 2-4 hrs after injection of 10 nmoles SP, this was not significant 327 
because of increased variability.  However, these effects of SP on mean LH concentrations were not 328 
reflected in either LH pulse frequency or pulse amplitude as neither parameter was significantly increased 329 
at either dose (Fig. 8B) 330 
 331 
Discussion 332 
This is the first detailed description of neurons containing SP and its cognate receptor, NK1R, in the 333 
ovine hypothalamus. Although SP was found in hypothalamic areas critical to the control of GnRH and 334 
LH secretion, the absence of NK1R in either GnRH- or kisspeptin-containing neurons argues against an 335 
important role for this tachykinin in control of reproductive function.  The pharmacological data 336 
demonstrating that much higher doses of SP and NKA, than of NKB, are needed to stimulate LH 337 
secretion also supports this conclusion. 338 
 Although there has been considerable work describing the expression of SP in the ovine 339 
peripheral nervous system and one report of SP-immunoreactive cells in the pars tuberalis of sheep (51), 340 
there has been no description of SP-containing neurons in the hypothalamus of this species.  We observed 341 
that these neurons were largely limited to the ARC, a distribution similar to that reported in humans (52) 342 
and monkeys (38,53).  In contrast, SP-containing neural cell bodies are found in several other 343 
hypothalamic regions in rodents, including the POA, anterior hypothalamic area, and premammillary 344 
region (PMR) (12,54,55). It is important to point out, however, that an ICC analysis may not detect all 345 
SP-producing neurons.  For example, in situ hybridization identified cells containing mRNA for SP in the 346 
POA and PMR of humans (56) and there is a similar mismatch between mRNA and protein expression 347 
for dynorphin in some regions of the ovine hypothalamus (57).  In contrast to the limited distribution of 348 
SP-immunoreactive cells, NK1R-expressing cells were observed in several different regions of the ovine 349 
diencephalon, with relatively high expression in the lateral POA, the ventromedial nucleus, the caudal 350 
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ARC, and the PMR. A similar distribution of NK1R has been observed in rats (58) and guinea pigs (59).  351 
Although NK1R has been detected in the human hypothalamus (60), there is no detailed description of its 352 
expression in specific hypothalamic nuclei. 353 
 In contrast to the high level of colocalization of NKB and kisspeptin previously reported in the 354 
ovine ARC (8), we found that very few kisspeptin-containing neurons in this nucleus also expressed SP 355 
and no colocalization of SP and kisspeptin in the POA was observed. These observations conflict with the 356 
recent report that SP-immunoreactivity was found in 30% of kisspeptin neurons in the human 357 
infundibular region (36), but are consistent with the lack of Tac1 mRNA in Kiss1 neurons in either the 358 
AVPV/PeN or ARC of mice (12).  These data raise the possibility of differences among species in 359 
expression of SP in kisspeptin neurons.  In this regard it is interesting to note that essentially no 360 
colocalization of these two peptides was recently observed in tissue from gonadally-intact and castrated 361 
male monkeys (38).  It is also unlikely that endocrine status can account for these differences as tissue 362 
from post-menopausal women, OVX mice, and castrated monkeys were used in these three studies. 363 
 In light of the accumulating evidence that activation of NK1R signaling stimulates LH secretion 364 
in rodents (see Introduction), we hypothesized that NK1R would be found in either GnRH or kisspeptin 365 
neurons in the sheep.  However, our data do not support this hypothesis: no GnRH neurons or POA 366 
kisspeptin neurons contained NK1R, and only 6% of KNDy neurons contained this receptor.  In mice, 49 367 
% of KNDy neurons, 27% of AVPV/PeN Kiss1 neurons, and 23% of GnRH neurons also contain Tacr1 368 
mRNA, based on single cell RT-PCR analysis (12); data on the expression of NK1R in these neurons is 369 
not currently available in any other species. It is possible that immunocytochemistry failed to detect 370 
NK1R in our study, but the similar anatomy of NK1R-containg neurons in rodents and sheep, and the 371 
robust expression of NK1R in ARC neurons not containing kisspeptin argue against this.  Moreover, 372 
using a similar approach we have observed that the majority of KNDy neurons contain NK3R in sheep 373 
(19). Thus these anatomical differences in NK1R expression most likely reflect functional differences in 374 
the role of NK1R signaling between these species.  Finally, although we did not examine expression of 375 
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NK2R in this study, previous work found no expression of NK2R in the hypothalamus of rats (48) and no 376 
coexpression of this receptor in murine kisspeptin or GnRH neurons (12). 377 
 In the second part of this study we determined the minimal dose of NKB, NKA, and SP needed to 378 
stimulate LH secretion when given into the third ventricle of ovary-intact anestrous ewes. Ewes were 379 
much more sensitive to NKB, with 0.2 nmole producing a consistent increase in LH concentrations, while 380 
2.0 nmoles of NKA and 10 nmoles of SP were needed to produce the same effect.  A lower dose of NKB  381 
(0.1 nmole) consistently produced an initial increase, but mean LH concentrations during the 2 hr post-382 
injection was not significantly higher than controls because of its relatively short duration.  Thus, the 383 
minimal dose of NKB needed to increase LH secretion probably falls between 0.2 and 0.1 nmoles. The 384 
minimal effective dose of NKB in this study is lower than that needed to increase bursts of multi-unit 385 
electrical activity (MUA) in goats (44), but this may in part be due to differences in the site of 386 
administration, since NKB was injected into the lateral ventricle in that study. It is interesting to note that 387 
the relative potency of these three tachykinins (NKB>NKA>SP) parallels the relative selectivity of 388 
NK3R, not that of NK1R (SP>NKA>NKB) or NK2R (NKA>NKB>SP) (5). This correlation raises the 389 
possibility that each of these three tachykinins produces its stimulatory effects on LH secretion in the ewe 390 
via NK3R.  This possibility is supported by the recent report that a selective NK3R agonist is much more 391 
potent at increasing bursts of MUA and LH pulses in OVX goats than selective NK1R or  NK2R agonists 392 
(61) and by reports that three different selective NK3R antagonists each inhibits episodic LH secretion in 393 
OVX ewes (14-16). 394 
. The conclusion that NK3R-signaling is the predominant pathway by which tachykinins control 395 
LH secretion in sheep and goats contrasts with recent data in rodents supporting a role for all three 396 
tachykinin receptors.  This evidence includes reports that: 1) equivalent doses of selective agonists to 397 
NK1R, NK2R, and NK3R increase LH secretion in mice (12) and rats (32); 2) NKA and SP can stimulate 398 
electrical activity of KNDy neurons in vitro (25); and 3) antagonists to all three tachykinin receptors are 399 
required to completely block the stimulatory effects of NKB on the electrical activity of KNDy neurons 400 
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(25) and episodic LH secretion in OVX rats (34).   Thus there appears to be species differences between 401 
rodents and ruminants in the ability of signaling via NK1R or NK2R to stimulate LH secretion.   402 
 In light of this apparent species difference in redundancy within tachykinin signaling critical for 403 
LH secretion, it is of interest to assess the situation in humans and non-human primates. At this time there 404 
is no data on colocalization of any tachykinin receptor in GnRH or kisspeptin neurons in these species, 405 
but there are a few functional and more extensive genetic studies.  In monkeys, the number of SP-406 
containing neurons increases following castration (38), but iv administration of SP had no effect on LH 407 
secretion (38) and a selective antagonist to NK3R inhibited LH secretion in castrated males and ovary-408 
intact females during the follicular phase of the menstrual cycle (16).  Thus, most data are consistent with 409 
a lack of redundancy in tachykinin signaling in non-human primates.  The situation in humans appears to 410 
be more complex.  Two observations support redundancy: 1) in women, expression of mRNA for SP 411 
increases after menopause (6) and 2) in men, iv infusion of SP can stimulate LH secretion (35).  On the 412 
other hand, the infertility observed in patients with mutations that disrupt NKB-NK3R signaling argues 413 
against redundancy (1-3,62,63), although the reversibility of this condition in some individuals (2,64) 414 
could be due to signaling via other tachykinin receptors. Finally, the recent report that the selective NK3R 415 
antagonist, ESN364, inhibits LH secretion in men and women (17), as it does in sheep and monkeys (16) 416 
provides strong evidence that signaling through NK1R or NK2R plays a minor role in the control of LH 417 
secretion in humans.  This conclusion, if correct, would provide a simple explanation for the differences 418 
in the severity of infertility produced by genetic disruption of NKB-NK3R signaling in humans (1-419 
3,62,63) and mice (65,66). 420 
In summary, this study provides the first detailed description of the expression of SP- and NK1R-421 
immunoreactivity within the ovine POA and hypothalamus. In contrast to data in humans and mice, but 422 
consistent with data in male monkeys, we found little colocalization of SP with kisspeptin.  Moreover, the 423 
lack of expression in NK1R within GnRH- and kisspeptin-containing neurons and the relatively high 424 
doses of NKA and SP needed to stimulate LH secretion in ewes, support the hypothesis that NKB-NK3R 425 
signaling is the predominant pathway by which tachykinins control LH secretion in this species.  426 
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Figure legends 654 
Fig. 1. Camera lucida drawings illustrating the representative distribution of SP (circles) and NK1R 655 
(triangles) cell bodies in the preoptic area and hypothalamus of the ewe. Each marking represents 656 
approximately 10 cell bodies. Note that SP cell bodies were found only in the middle and caudal ARC (F-657 
H).  The distribution of SP and NK1R is shown unilaterally to allow visualization of labels. A15, A15 658 
dopaminergic neurons; ac, anterior commissure; AHA, anterior hypothalamic area; r-m-c-ARC, rostral, 659 
middle and caudal ARC; BNST, bed nucleus of the stria terminalis; CP, cerebral peduncle; DMH, 660 
dorsomedial nucleus of the hypothalamus; fx, fornix; GP, globus pallidus; LHA, lateral hypothalamic 661 
area; me, median eminence; MM, mammillary body; mPOA, medial preoptic area; mr, mammillary 662 
recess; mt, mammillary tract; OC, optic chiasm; ot, optic tract; OVLT, organum vasculosum of lamina 663 
terminalis; PH, posterior hypothalamus; PMv, ventral premammillary nucleus; pt, pars tuberalis of the 664 
adenohypophysis; PVN, paraventricular nucleus; SON, supraoptic nucleus; TMv, ventral 665 
tuberomammillary nucleus; VMH, ventromedial nucleus of the hypothalamus; 3v, third ventricle. 666 
 667 
Fig. 2. Representative fluorescence photomicrographs showing lack of colocalization of  kisspeptin 668 
(green) and SP (red) (Panels A, B) and kisspeptin (green) and  NK1R (red)  (Panels C, D) in the ARC (A, 669 
C) and POA (B, D). All photomicrographs are the computerized merger of two separate images captured 670 
simultaneously with the appropriate excitation for either DyLight 488 (green: kisspeptin) or Alexa 555  671 
(red: SP or NK1R). Scale bar: (A), 100 µm; (B-D), 50 µm. 3v: third ventricle.  672 
 673 
Fig. 3. Representative fluorescence photomicrographs showing lack of colocalization of  GnRH (green) 674 
and SP (red) (Panels A, B) and GnRH (green) and  NK1R (red) (Panels C, D) in the ARC (A, C) and 675 
POA (B, D). All photomicrographs are the computerized merger of two separate images captured 676 
simultaneously  with the appropriate excitation for either DyLight 488 (green) or Alexa 555  (red).Scale 677 
bar: (A), 100 µm; (B-D), 50 µm. GP: globus pallidus; 3v: third ventricle. 678 
 679 
25 
 
Fig. 4. Mean ± SEM total number of kisspeptin (A) and NK1R (B) cells in the rostral, middle and caudal 680 
aspects of the ARC, in OVX (white bars) and OVX+ E2 (black bars) ewes. Representative fluorescence 681 
photomicrographs from tissue stained for kisspeptin (green) and NK1R (red) in the caudal ARC of OVX 682 
(C) and OVX+ E2 (D) ewes. Scale bar: 100 µm. 3v: third ventricle. * P<0.05 during comparison of OVX 683 
and OVX+ E2 in each aspect of the ARC. 684 
 685 
Fig 5. Effects of different doses of NKB administered as a single injection into the third ventricle.  Mean 686 
(±SEM) LH concentrations before (open bars) and 2 hrs after (solid bars) injection are shown.  *P<0.05 687 
vs corresponding value for control (0 dose) injection. 688 
 689 
Fig 6. Representative LH patterns before and after third ventricular injection (arrows) of artificial CSF 690 
(aCSF), NKA, and SP.  Left panels depict LH data from the same ewe for the first set of treatments, while 691 
data from the second set of treatments in a different ewe are depicted in the right panel. Doses (in nmoles) 692 
of NKA or SP are presented in parentheses and peaks of LH pulses are indicated by solid circles.  693 
 694 
Fig 7.  Top panel (A): Effect of two doses of NKA on mean LH concentrations before (open bars), 0-2 hrs 695 
(grey bars) and 2-4 hrs (black bars) after injection. *P<0.05 vs corresponding value for control (0 dose) 696 
treatment. Bottom panel (B): Dose-response of NKA on LH pulse frequency (bars on left) and pulse 697 
amplitude (bars on right) during the 4 hrs after injection of this tachykinin. . *P<0.05 vs control (0 dose). 698 
 699 
Fig 8.  Top panel (A): Effect of two doses of SP on mean LH concentrations before (open bars), 0-2 hrs 700 
(grey bars) and 2-4 hrs (black bars) after injection. *P<0.05 vs corresponding value for control (0 dose) 701 
treatment. Bottom panel (B):  Effect of two doses of SP on LH pulse frequency (bars on left) and pulse 702 
amplitude (bars on right) during the 4 hrs after injection of this tachykinin. There were no statistically 703 
significant effects. Note differences in doses between NKA (Fig. 7) and SP. 704 
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Table 1. Primary antibodies used 706 
Peptide/protein 
target 
Antigen sequence  
(if known) 
Name of 
Antibody 
Manufacturer, catalog #, and/or 
name of individual providing the 
antibody 
Species raised in; 
monoclonal or 
polyclonal 
Dilution 
used 
Substance P CRPKPQQFFGLM Anti-Substance P antibody Abcam, ab10353; Lot GR29977-16 Guinea Pig, polyclonal 1:4,000 
NK1R 
23 aa sequende (385-
407) of COOH end of 
rat SP receptor 
Anti-Substance P 
Receptor 
antibody 
Millipore, AB 5060, Lot 2135068 Rabbit, polyclonal 1:10,000 
Kisspeptin Peptide from mouse kisspeptin 10 
Anti-kisspeptin 
antibody Millipore, AB9754, and Lot 2397065 Rabbit, polyclonal 1:1,000 
GnRH 
Synthetic GnRH 
coupled to keyhole 
limpet hemocyanin 
with carbodiimide 
linker 
LHRH antibody Immunostar, 20075, lot 1037001 Rabbit, polyclonal 1:400 
  707 
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Table 2.  Effect of NKB on LH pulse frequency and amplitude 708 
Dose of NKB (nmoles)    Frequency (#/2hrs)  Amplitude (ng/ml) 709 
0    0 ± 0        ND 710 
 0.05           0.25 ± 0.22       ND 711 
         0.1             1.0 ± 0*    2.4 ± 0.5 712 
 0.2             1.5 ± 0.3*   4.7 ± 0.9 713 
 0.5             1.5 ± 0.3*   3.1 ± 0.9  714 
*P<0.05 compared to 0 nmoles NKB; ND: not determined due to low number of pulses  715 
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